Integra Lifesciences
(IART)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 232,186 | 217,914 | 239,104 | 246,375 | 215,157 |
| Marketable Securities | 35,693 | 35,694 | 34,191 | 27,192 | 62,441 |
| Receivables | 262,160 | 284,507 | 252,446 | 272,370 | 248,298 |
| Inventories | 489,106 | 465,127 | 445,418 | 429,090 | 436,930 |
| Other current assets | 30,326 | 36,121 | 32,214 | 29,653 | 50,370 |
| TOTAL | $1,143,582 | $1,142,828 | $1,107,247 | $1,081,681 | $1,099,522 |
| Non-Current Assets | |||||
| PPE Net | 437,367 | 434,816 | 422,913 | 405,723 | 390,906 |
| Intangibles | 1,775,344 | 1,804,507 | 2,292,921 | 2,304,540 | 2,326,083 |
| Other Non-Current Assets | 290,159 | 285,754 | 229,670 | 245,480 | 249,292 |
| TOTAL | $2,502,870 | $2,525,077 | $2,945,504 | $2,955,743 | $2,966,281 |
| Total Assets | $3,646,452 | $3,667,905 | $4,052,751 | $4,037,424 | $4,065,803 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 574,628 | 573,899 | 573,170 | 572,442 |
| Accounts payable and accrued liabilities | 92,305 | 92,835 | 91,296 | 82,502 | 77,666 |
| Accrued Expenses | 207,847 | 198,314 | 189,797 | 207,525 | 208,363 |
| Other current liabilities | 11,326 | 11,103 | 10,539 | 10,483 | 9,990 |
| TOTAL | $364,054 | $929,806 | $918,452 | $922,126 | $912,563 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,792,351 | 1,226,942 | 1,230,641 | 1,196,017 | 1,205,092 |
| Other Non-Current Liabilities | 394,188 | 412,432 | 321,938 | 313,168 | 357,616 |
| TOTAL | $2,244,824 | $1,699,438 | $1,610,160 | $1,570,018 | $1,631,653 |
| Total Liabilities | $2,608,878 | $2,629,244 | $2,528,612 | $2,492,144 | $2,544,216 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,892 | 77,911 | 77,712 | 77,219 | 77,164 |
| Common Shares | 923 | 923 | 921 | 916 | 916 |
| Retained earnings | 425,145 | 430,549 | 914,622 | 939,915 | 920,481 |
| Other shareholders' equity | -32,000 | -30,941 | -24,485 | -27,982 | -24,664 |
| TOTAL | $1,037,574 | $1,038,661 | $1,524,139 | $1,545,280 | $1,521,587 |
| Total Liabilities And Equity | $3,646,452 | $3,667,905 | $4,052,751 | $4,037,424 | $4,065,803 |